Latest debt-to-equity ratio
Cue Biopharma Debt-to-equity ratio
Direct answer
Cue Biopharma's debt-to-equity ratio is 133.2%.
The verified market snapshot reports 133.2%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Cue Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 133.2%
Explore related company data
View Cue Biopharma's market capitalizationView Cue Biopharma's price-to-book ratioView Cue Biopharma's return on equityView Cue Biopharma's dividend yieldView Cue Biopharma's 52-week price rangeView Cue Biopharma's revenue growthView Cue Biopharma's profit marginView all Cue Biopharma key metricsReturn to Cue Biopharma profile